IP Verse

Tumor-Treating Pharmaceutical Composition

Patent No. EP3581183 (titled "Tumor-Treating Pharmaceutical Composition") was filed by Eisai R&D Management on Feb 6, 2018. The application was issued on Nov 29, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STADA ARZNEIMITTELAug 29, 2024HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3581183

EISAI R&D MANAGEMENT
Application Number
EP18751614A
Filing Date
Feb 6, 2018
Status
Granted And Under Opposition
Oct 27, 2023
Publication Date
Nov 29, 2023
External Links
Slate, Register , Google Patents